Jefferies Reaffirms Their Hold Rating on Great Portland Estates plc R.E.I.T. (GPE)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Prew is a 4-star analyst with an average return of 5.0% and a 56.58% success rate.
The word on The Street in general, suggests a Hold analyst consensus rating for Great Portland Estates plc R.E.I.T. with a p321.71 average price target, representing a -1.01% downside. In a report released on May 12, UBS also maintained a Hold rating on the stock with a p330.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Why Is Freshpet (FRPT) Stock Soaring Today
What Happened? Shares of pet food company Freshpet (NASDAQ:FRPT) jumped 6.2% in the morning session after Jefferies upgraded the stock, citing strong growth prospects for the company. The investment firm raised its rating on the stock to 'Buy' from 'Hold' and boosted its price target to $150 from $115. Jefferies analyst Rob Dickerson pointed to the company's accelerating sales growth and expanding retail footprint as key reasons for the bullish turn. The analyst noted that Freshpet is successfully adding new manufacturing capacity, or "Kitchens," and increasing the number of its branded refrigerators in stores, which should fuel further growth. This expansion is expected to not only drive top-line revenue but also lead to improved profitability through margin expansion as the company scales its operations. The new $150 price target suggests a significant potential upside for the shares. Is now the time to buy Freshpet? Access our full analysis report here, it's free. What Is The Market Telling Us Freshpet's shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 5 months ago when the stock dropped 19.5% on the news that the company reported disappointing fourth-quarter results: its gross margin missed significantly, and its full-year revenue guidance fell short of Wall Street's estimates. On the other hand, Freshpet blew past analysts' EBITDA expectations. The company also guided for full-year EBITDA above Wall Street's estimates. Still, this was a softer quarter due to the worse-than-anticipated top-line momentum for 2025. Freshpet is down 49.4% since the beginning of the year, and at $73.05 per share, it is trading 55.1% below its 52-week high of $162.59 from January 2025. Investors who bought $1,000 worth of Freshpet's shares 5 years ago would now be looking at an investment worth $817.93. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Yahoo
3 hours ago
- Yahoo
Why Zions Bancorporation (ZION) Stock Is Up Today
What Happened? Shares of regional banking company Zions Bancorporation (NASDAQ:ZION) jumped 3.5% in the pre-market session after the company reported better-than-expected second-quarter financial results and received positive attention from Wall Street analysts. The regional bank announced robust earnings for the second quarter, posting earnings per share of $1.63, which significantly beat the consensus estimate of $1.31. Revenue also surpassed expectations, coming in at $838 million against a forecast of $811.06 million. The strong performance was driven by an expanding net interest margin, which is the difference between the interest income a bank earns from its lending activities and the interest it pays to depositors. Following the strong earnings report, Jefferies upgraded Zions' stock from "Underperform" to "Hold" and substantially raised its price target from $45 to $60. Analysts at DA Davidson also boosted their price target to $66 from $57, maintaining a "Buy" rating and noting that management is "incrementally more optimistic" about the second half of the year. After the initial pop the shares cooled down to $57.18, up 1% from previous close. Is now the time to buy Zions Bancorporation? Access our full analysis report here, it's free. What Is The Market Telling Us Zions Bancorporation's shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Zions Bancorporation is up 5.8% since the beginning of the year, and at $57.18 per share, it is trading close to its 52-week high of $61.73 from November 2024. Investors who bought $1,000 worth of Zions Bancorporation's shares 5 years ago would now be looking at an investment worth $1,718. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Jefferies Downgrades Clarivate (CLVT) to Hold From Buy, Brings PT Down to $4.50
Clarivate Plc (NYSE:CLVT) is one of the best affordable stocks under $5 to invest in. On July 18, Jefferies downgraded Clarivate Plc (NYSE:CLVT) to Hold from Buy, bringing the price target down to $4.50 from $5.20. Clarivate Plc (CLVT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 A state-of-the-art computer lab filled with engineers working on new analytics technologies. The firm told investors that although Clarivate Plc (NYSE:CLVT) reported better-than-expected fiscal Q1 2025 results, investors are underestimating the time it would take for the company to unlock value, either through divestitures or organic means. Jefferies sees Clarivate Plc's (NYSE:CLVT) 2026 revenue as flat with 2025 levels, and risk to its business operations due to the current administration's plans to cut funding for the National Institutes of Health and post-secondary education. The firm thus sees Clarivate Plc (NYSE:CLVT) trading sideways in the near term, justifying the downgrade. Clarivate Plc (NYSE:CLVT) provides global information, workflow solutions, and analytics. The company operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). While we acknowledge the potential of CLVT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
